5 Best UK Stocks to Buy Now

4. LivaNova PLC (NASDAQ:LIVN)

Number of Hedge Fund Holders: 31

LivaNova PLC (NASDAQ:LIVN) is a London-based medical device company catering mainly to neuromodulation and cardiac patients. The company distributes its products to neurologists, neurosurgeons, and other healthcare providers. On April 5, Wolfe Research analyst Mike Polark initiated coverage of LivaNova PLC (NASDAQ:LIVN) with an Outperform rating and a $95 price target.

The stock has gained close to 12% in the last month. LivaNova PLC (NASDAQ:LIVN)’s revenue for 2021 came in at over $1 billion, compared to $934.2 million in the previous year. The net income in 2021 also gained over 61% from 2020. 

According to Insider Monkey’s Q4 data, 31 hedge funds were bullish on LivaNova PLC (NASDAQ:LIVN), with combined stakes worth $1.2 billion. Harris Associates owned the leading position in the company, with 3.8 million shares valued at $334.2 million. 

Here is what Diamond Hill Small Cap Fund has to say about LivaNova PLC (NASDAQ:LIVN) in its Q3 2021 investor letter:

“Our health care holdings were negative in aggregate, but outpaced index peers, which boosted relative performance along with our below-benchmark positioning on an individual holdings’ basis, we exited global medical technology company LivaNova as shares approached our estimate of intrinsic value.”